| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
22,496 |
19,525 |
$5.78M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
18,814 |
13,245 |
$180K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
7,381 |
4,935 |
$104K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
1,044 |
922 |
$61K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,102 |
2,934 |
$57K |
| 51798 |
|
1,317 |
930 |
$8K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
706 |
551 |
$6K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
60 |
41 |
$2K |
| 90686 |
|
182 |
140 |
$575.29 |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
29 |
29 |
$541.33 |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
126 |
121 |
$393.62 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
14 |
14 |
$260.00 |
| 17110 |
|
20 |
13 |
$199.56 |
| 81003 |
|
1,699 |
1,293 |
$196.55 |
| 81002 |
|
134 |
128 |
$165.35 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
128 |
96 |
$112.93 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
101 |
64 |
$86.91 |
| 90656 |
|
16 |
13 |
$69.78 |
| 85018 |
|
156 |
154 |
$33.81 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
42 |
33 |
$21.91 |
| 1159F |
|
9,914 |
8,693 |
$0.00 |
| 1160F |
|
9,809 |
8,603 |
$0.00 |
| 3078F |
|
847 |
766 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
23 |
15 |
$0.00 |
| 82948 |
|
38 |
25 |
$0.00 |
| 3077F |
|
25 |
24 |
$0.00 |
| Q0091 |
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory |
16 |
12 |
$0.00 |
| 3008F |
|
6,247 |
5,871 |
$0.00 |
| 3074F |
|
709 |
655 |
$0.00 |
| 3075F |
|
75 |
70 |
$0.00 |
| 3079F |
|
62 |
55 |
$0.00 |